Clinical trial · Observational
Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records
Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records (GRECO)
NCT03625557CI-TRIAL-00044717completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To document the clinical outcomes of cancer patients who received the Guardant360® test and agree to share their records with Guardant Health.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Hematologic Malignancy | Non-Hematologic Malignancy | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Objective response rate (ORR)
- timeFrame
- 3 years
- description
- Portion of patients with tumors that are found to have complete or partial response
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
General Inclusion Criteria: * Adults (≥ 18 years old) with a diagnosis of Stage 3 or Stage 4 cancer (non-hematologic malignancy). Patients with advanced cancers not typically staged 1-4 (such as extensive stage small lung cancer) may be enrolled. * Results from Guardant360® test * Patient has previously provided contact information (either email or phone) to Guardant Health. * Able and wiling to complete the informed consent process. * Willingness to consent to the release of medical records. * Willingness to provide Medical Records Release General Exclusion Criteria: * Unwilling or unable to provide written informed consent. * Unable to understand English. * Diagnosis of NSCLC * Guardant 360® test results released to the patient's physician no less than 14 days and no greater than 60 days prior to initial patient contact.
References
Publications (0)
Data not yet available
No reference posted for this study.